Wealthedge Investment Advisors’s Boston Scientific BSX Stock Holding History

Wealthedge Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19M	Buy	+51,395	New	+$2.79M	0.75%	38

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wealthedge Investment Advisors's BSX Position: Q2 2026 in Review

Wealthedge Investment Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 51,395 shares worth $2.19M. The stake represents 0.75% of the portfolio and ranks #38 among its holdings.

844 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Wealthedge Investment Advisors held 51,395 shares of Boston Scientific worth $2.19M as of Q2 2026.
Boston Scientific was a new Wealthedge Investment Advisors position in Q2 2026.
Boston Scientific made up 0.75% of Wealthedge Investment Advisors's portfolio in Q2 2026, its #38 holding.
844 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wealthedge Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.